Am J Cardiol

1. EDMONSTON D, Mulder H, Lydon E, Chiswell K, et al
   Kidney and Cardiovascular Effectiveness of Empagliflozin Compared to Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes.
   Am J Cardiol. 2024 Apr 17:S0002-9149(24)00268.
   

   >> Share

   
   

   
   Am J Manag Care

2. KUMAR A, Dowd-Green C, Green R, Stewart R, et al
   Institutional practices for charitable medication access for uninsured patients.
   Am J Manag Care. 2024;30:e135-e139.
   

   >> Share

   
   

   
   Am J Ophthalmol

3. WAI KM, Mishra K, Koo E, Ludwig CA, et al
   Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.
   Am J Ophthalmol. 2024 Apr 16:S0002-9394(24)00150.
   

   >> Share

   
   

   
   Ann Intern Med

4. DRAKE T, Landsteiner A, Langsetmo L, MacDonald R, et al
   Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians.
   Ann Intern Med. 2024 Apr 19. doi: 10.7326/M23-1490.
   

   >> Share

   
   
5. SCHOUSBOE JT, Landsteiner A, Drake T, Sultan S, et al
   Cost-Effectiveness of Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review of Cost-Effectiveness Studies for the American College of Physicians.
   Ann Intern Med. 2024 Apr 19. doi: 10.7326/M23-1492.
   

   >> Share

   
   
6. QASEEM A, Obley AJ, Shamliyan T, Hicks LA, et al
   Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians.
   Ann Intern Med. 2024 Apr 19. doi: 10.7326/M23-2788.
   

   >> Share

   
   
7. SYED FZ
   Pharmacologic Treatments in Adults With Type 2 Diabetes: Cost-Effectiveness and Comorbidity Considerations.
   Ann Intern Med. 2024 Apr 19. doi: 10.7326/M24-0861.
   

   >> Share

   
   
8. 
   Annals Video Summary - Newer Pharmacologic Treatments in Adults With Type 2 Diabetes.
   Ann Intern Med. 2024 Apr 19:eM231554. doi: 10.7326/M23-1554.
   

   >> Share

   
   
9. 
   Visual Guideline - Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Visual Clinical Guideline From the American College of Physicians.
   Ann Intern Med. 2024 Apr 19:eM240803. doi: 10.7326/M24-0803.
   

   >> Share

   
   
10. HWANG JH, Hsu CY
    In CKD, empagliflozin reduced kidney disease progression at a median 2 y, regardless of primary kidney disease type.
    Ann Intern Med. 2024;177:JC40.
    

    >> Share

    
    
11. EGAN AM
    In T2DM, periconceptional, noninsulin, second-line antidiabetes medications were not linked to major congenital malformations vs. insulin.
    Ann Intern Med. 2024;177:JC47.
    

    >> Share

    
    

    
    BMC Ophthalmol

12. LEE SH, Lee GW, Lee SJ, Kim SG, et al
    Association between the response of intravitreal antivascular endothelial growth factor injection and systemic factors of diabetic macular edema.
    BMC Ophthalmol. 2024;24:166.
    

    >> Share

    
    

    
    BMJ

13. NOLAN T
    The use of continuous glucose monitoring devices in non-diabetic adults ... and other research.
    BMJ. 2024;385:q859.
    

    >> Share

    
    
14. SETHI J
    Breaking free from the stigma of diabetes.
    BMJ. 2024;385:q890.
    

    >> Share

    
    

    
    Circulation

15. NEUEN BL, Tuttle KR, Vaduganathan M
    Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease.
    Circulation. 2024;149:1238-1240.
    

    >> Share

    
    

    
    Diabet Med

16. KICKOVA T, Skopkova M, Dobiasova Z, Lackova G, et al
    An alternative approach using hs-CRP levels and age of onset in diagnostics of HNF1A-MODY.
    Diabet Med. 2024;41:e15265.
    

    >> Share

    
    
17. 
    Abstracts of the Diabetes UK Professional Conference 2024, ExCeL London, 17-19 April 2024.
    Diabet Med. 2024;41 Suppl 1:e15296.
    

    >> Share

    
    
18. 
    Abstracts of the Diabetes UK Professional Conference 2024, ExCeL London, 17-19 April 2024.
    Diabet Med. 2024;41 Suppl 1:e15295.
    

    >> Share

    
    
19. 
    Abstracts of the Diabetes UK Professional Conference 2024, ExCeL London, 17-19 April 2024.
    Diabet Med. 2024;41 Suppl 1:e15294.
    

    >> Share

    
    

    
    Diabetes

20. GUPTA OT, Gupta RK
    The Expanding Problem of Regional Adiposity: Revisiting a 1985 Diabetes Classic by Ohlson et al.
    Diabetes. 2024;73:649-652.
    

    >> Share

    
    
21. AMANDA DK
    A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology. Diabetes 2023;72:812-818.
    Diabetes. 2024;73:e1-e2.
    

    >> Share

    
    

    
    Diabetes Care

22. JACOBSEN LM, Cuthbertson D, Bundy BN, Atkinson MA, et al
    Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy Trials.
    Diabetes Care. 2024 Apr 15:dc240171. doi: 10.2337/dc24-0171.
    

    >> Share

    
    
23. YAO P, Iona A, Pozarickij A, Said S, et al
    Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.
    Diabetes Care. 2024 Apr 16:dc232145. doi: 10.2337/dc23-2145.
    

    >> Share

    
    
24. PASSANISI S, Salzano G, Bombaci B, Minuto N, et al
    Sustained Effectiveness of an Advanced Hybrid Closed Loop System in a Cohort of Children and Adolescents With Type 1 Diabetes: A 1-Year Real-World Study.
    Diabetes Care. 2024 Apr 16:dc232311. doi: 10.2337/dc23-2311.
    

    >> Share

    
    
25. LI M, Li J, Xu Y, Gao J, et al
    Effect of 5:2 Regimens: Energy-Restricted Diet or Low-Volume High-Intensity Interval Training Combined With Resistance Exercise on Glycemic Control and Cardiometabolic Health in Adults With Overweight/Obesity and Type 2 Diabetes-A Three-Arm Randomized
    Diabetes Care. 2024 Apr 18:dc240241. doi: 10.2337/dc24-0241.
    

    >> Share

    
    
26. ZEITLER P, Galindo RJ, Davies MJ, Bergman BK, et al
    Early-Onset Type 2 Diabetes and Tirzepatide Treatment: A Post Hoc Analysis From the SURPASS Clinical Trial Program.
    Diabetes Care. 2024 Apr 19:dc232356. doi: 10.2337/dc23-2356.
    

    >> Share

    
    
27. HAMIDI V, Pettus JH
    Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?
    Diabetes Care. 2024;47:782-784.
    

    >> Share

    
    
28. KAYLAN KB, Philipson LH
    Werner Syndrome and Diabetes: Opportunities for Precision Medicine.
    Diabetes Care. 2024;47:785-786.
    

    >> Share

    
    
29. MOZAFFARIAN D
    Plant-Based Diets and Diabetes Risk: Which Foods, What Mechanisms?
    Diabetes Care. 2024;47:787-789.
    

    >> Share

    
    
30. BEATO-VIBORA PI, Chico A, Moreno-Fernandez J, Bellido-Castaneda V, et al
    Response to Comment on Beato-Vibora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-world Setting. Diabetes Care 2024;47:216-224.
    Diabetes Care. 2024;47:e46-e47.
    

    >> Share

    
    
31. SCHEUER SH, Andersen GS, Carstensen B, Diaz L, et al
    Trends in Incidence of Hospitalization for Hypoglycemia and Diabetic Ketoacidosis in Individuals With Type 1 or Type 2 Diabetes With and Without Severe Mental Illness in Denmark From 1996 to 2020: A Nationwide Study.
    Diabetes Care. 2024 Apr 19:dc232394. doi: 10.2337/dc23-2394.
    

    >> Share

    
    
32. LEBBAR M, Henry Z, Thivolet C
    Comment on Beato-Vibora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-World Setting. Diabetes Care 2024;47:216-224.
    Diabetes Care. 2024;47:e44-e45.
    

    >> Share

    
    

    
    Diabetes Obes Metab

33. JEONG SI, Ban MS, Hwang JG, Park MK, et al
    The effect of renal function on the pharmacokinetics and pharmacodynamics of enavogliflozin, a potent and selective sodium-glucose cotransporter-2 inhibitor, in type 2 diabetes.
    Diabetes Obes Metab. 2024 Apr 15. doi: 10.1111/dom.15573.
    

    >> Share

    
    
34. 
    Correction to "Defining diabetes status using medication groups in Medicare data: Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time".
    Diabetes Obes Metab. 2024 Apr 19. doi: 10.1111/dom.15618.
    

    >> Share

    
    
35. HU Y, Li X, Wang X, Ma H, et al
    Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank.
    Diabetes Obes Metab. 2024 Apr 15. doi: 10.1111/dom.15603.
    

    >> Share

    
    
36. WILSON M, Al-Hamid A, Abbas I, Birkett J, et al
    Identification of diagnostic biomarkers used in the diagnosis of cardiovascular diseases and diabetes mellitus: A systematic review of quantitative studies.
    Diabetes Obes Metab. 2024 Apr 18. doi: 10.1111/dom.15593.
    

    >> Share

    
    
37. WANG Y, Jiang C, Dong X, Chen M, et al
    Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial.
    Diabetes Obes Metab. 2024 Apr 15. doi: 10.1111/dom.15596.
    

    >> Share

    
    
38. DENG S, Hu X, Zhang X
    Association of single-point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes.
    Diabetes Obes Metab. 2024 Apr 15. doi: 10.1111/dom.15600.
    

    >> Share

    
    
39. MALIK RA, Hwu CM, Jammah AA, Arteaga-Diaz JM, et al
    Real-world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12-month, prospective observational study.
    Diabetes Obes Metab. 2024 Apr 18. doi: 10.1111/dom.15599.
    

    >> Share

    
    
40. DE OLIVEIRA COSTA J, Lin J, Milder TY, Greenfield JR, et al
    Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia.
    Diabetes Obes Metab. 2024 Apr 15. doi: 10.1111/dom.15597.
    

    >> Share

    
    

    
    Diabetologia

41. METSALA J, Risnes K, Persson M, Veijola R, et al
    Gestational age at birth and type 1 diabetes in childhood and young adulthood: a nationwide register study in Finland, Norway and Sweden.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06139.
    

    >> Share

    
    
42. KIM JY, Jin SM, Kang ES, Kwak SH, et al
    Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 18. doi: 10.1007/s00125-024-06155.
    

    >> Share

    
    
43. LI X, Donnelly LA, Slieker RC, Beulens JWJ, et al
    Trajectories of clinical characteristics, complications and treatment choices in data-driven subgroups of type 2 diabetes.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06147.
    

    >> Share

    
    
44. SACCO S, Foschi M, Ornello R, De Santis F, et al
    Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.
    Diabetologia. 2024 Apr 16. doi: 10.1007/s00125-024-06146.
    

    >> Share

    
    
45. KIM JY, Jin SM, Sim KH, Kim BY, et al
    Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial.
    Diabetologia. 2024 Apr 19. doi: 10.1007/s00125-024-06152.
    

    >> Share

    
    
46. KARAGIANNIS T, Malandris K, Avgerinos I, Stamati A, et al
    Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
    Diabetologia. 2024 Apr 13. doi: 10.1007/s00125-024-06144.
    

    >> Share

    
    

    
    Eur J Endocrinol

47. GETHER IM, Bahne E, Nerild HH, Rehfeld JF, et al
    Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling.
    Eur J Endocrinol. 2024;190:314-326.
    

    >> Share

    
    

    
    J Am Coll Cardiol

48. KITTIPIBUL V, Cox ZL, Chesdachai S, Fiuzat M, et al
    Genitourinary Tract Infections in Patients Taking SGLT2 Inhibitors: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2024;83:1568-1578.
    

    >> Share

    
    
49. WONG ND, Fan W, Hu X, Ballantyne C, et al
    Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.
    J Am Coll Cardiol. 2024;83:1511-1525.
    

    >> Share

    
    

    
    J Am Soc Nephrol

50. MAXWELL S, Okabe J, Kaipananickal H, Rodriguez H, et al
    Set7 Methyltransferase and Phenotypic Switch in Diabetic Glomerular Endothelial Cells.
    J Am Soc Nephrol. 2024 Apr 17. doi: 10.1681/ASN.0000000000000345.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

51. NERILD HH, Gilliam-Vigh H, Ellegaard AM, Forman JL, et al
    Expression of bile acid receptors and transporters along the intestine of patients with type 2 diabetes and controls.
    J Clin Endocrinol Metab. 2024 Apr 18:dgae261. doi: 10.1210.
    

    >> Share

    
    
52. 
    Correction to: "Differential Diagnosis of Post Pancreatitis Diabetes Mellitus Based on Pancreatic and Gut Hormone Characteristics".
    J Clin Endocrinol Metab. 2024 Apr 17:dgae232. doi: 10.1210.
    

    >> Share

    
    
53. GURUNG RL, Zheng H, Koh HWL, Yiamunaa M, et al
    Plasma proteomics of diabetic kidney disease among Asians with younger-onset type 2 diabetes.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae266. doi: 10.1210.
    

    >> Share

    
    
54. CHE J, He N, Kuang X, Zheng C, et al
    Dietary n-3 fatty acids intake and all-cause and cardiovascular mortality in patients with pre-diabetes and diabetes.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae265. doi: 10.1210.
    

    >> Share

    
    
55. LIANG Q, Li M, Huang G, Li R, et al
    Genetic Susceptibility, Mendelian randomization and Nomogram Model Construction of Gestational Diabetes Mellitus.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae200. doi: 10.1210.
    

    >> Share

    
    
56. DU X, Zhu Y, Lu W, Fu N, et al
    Regulation of the Function of T Follicular Helper Cells and B Cells in Type 1 Diabetes Mellitus by the OX40/OX40L Axis.
    J Clin Endocrinol Metab. 2024 Apr 16:dgae248. doi: 10.1210.
    

    >> Share

    
    
57. ZU P, Wang H, Zhang L, Bian H, et al
    Insulinemic and inflammatory dietary patterns show enhanced predictive potential for gestational diabetes mellitus risk.
    J Clin Endocrinol Metab. 2024 Apr 13:dgae238. doi: 10.1210.
    

    >> Share

    
    

    
    J Diabetes Complications

58. ZHAO D, Ma J, Sun Y, Huang W, et al
    Influence of trimetazidine on myocardial injury in mice with diabetic cardiomyopathy.
    J Diabetes Complications. 2024;38:108744.
    

    >> Share

    
    
59. KUFAISHI H, Mizrak HI, Brock B, Hansen TW, et al
    Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy - A Danes cohort study.
    J Diabetes Complications. 2024;38:108745.
    

    >> Share

    
    
60. SANTOS EAM, Zaccara TA, Paganoti CF, Peres SV, et al
    Association between extrapolated time in range and large for gestational age infants in pregnant women with type 1 diabetes.
    J Diabetes Complications. 2024;38:108724.
    

    >> Share

    
    

    
    J Exp Med

61. JOHNSON MB, Ogishi M, Domingo-Vila C, De Franco E, et al
    Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency.
    J Exp Med. 2024;221:e20231704.
    

    >> Share

    
    

    
    J Nutr

62. RILEY TM, Kris-Etherton PM, Hart TL, Petersen KS, et al
    Intake of Pistachios as a Nighttime Snack Has Similar Effects on Short- and Longer-Term Glycemic Control Compared with Education to Consume 1-2 Carbohydrate Exchanges in Adults with Prediabetes: A 12-Wk Randomized Crossover Trial.
    J Nutr. 2024;154:1219-1231.
    

    >> Share

    
    
63. XU G, Pan H, Fan L, Zhang L, et al
    Dietary Betaine Improves Glucose Metabolism in Obese Mice.
    J Nutr. 2024 Feb 26:S0022-3166(24)00112-3. doi: 10.1016/j.tjnut.2024.
    

    >> Share

    
    
64. QIN Y, Chen J, Qian D, Li Z, et al
    Excessive Tryptophan and Phenylalanine Induced Pancreatic Injury and Glycometabolism Disorder in Grower-finisher Pigs.
    J Nutr. 2024;154:1333-1346.
    

    >> Share

    
    

    
    JAMA

65. MACHIAVELLO ROMAN FJ, Azar MM, Trubin PA
    A Patient With Type 1 Diabetes and Acute Rhinosinusitis.
    JAMA. 2024 Apr 17. doi: 10.1001/jama.2024.0642.
    

    >> Share

    
    

    
    Med J Aust

66. TRAN DT, Falster MO, Pearse J, Mazevska D, et al
    The Australian Health Care Homes trial: quality of care and patient outcomes. A propensity score-matched cohort study.
    Med J Aust. 2024;220:372-378.
    

    >> Share

    
    

    
    Nat Genet

67. HUJOEL MLA, Handsaker RE, Sherman MA, Kamitaki N, et al
    Protein-altering variants at copy number-variable regions influence diverse human phenotypes.
    Nat Genet. 2024;56:569-578.
    

    >> Share

    
    

    
    Nature

68. LU YZ, Nayer B, Singh SK, Alshoubaki YK, et al
    CGRP sensory neurons promote tissue healing via neutrophils and macrophages.
    Nature. 2024;628:604-611.
    

    >> Share

    
    

    
    Ophthalmol Retina

69. MEHTA H, Gabrielle PH, Hashimoto Y, Kibret GD, et al
    One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry.
    Ophthalmol Retina. 2024 Apr 12:S2468-6530(24)00182.
    

    >> Share

    
    

    
    Ophthalmology

70. WENG CY, Maguire MG, Flaxel CJ, Jain N, et al
    Effectiveness of Conventional Digital Fundus Photography-Based Teleretinal Screening for Diabetic Retinopathy and Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.
    Ophthalmology. 2024 Apr 11:S0161-6420(24)00156.
    

    >> Share

    
    

    
    PLoS One

71. ZHAO L, Wang Y, Bawa EM, Meng Z, et al
    Identifying a group of factors predicting cognitive impairment among older adults.
    PLoS One. 2024;19:e0301979.
    

    >> Share

    
    
72. AKINLEYE A, Oremade O, Xu X
    Exposure to low levels of heavy metals and chronic kidney disease in the US population: A cross sectional study.
    PLoS One. 2024;19:e0288190.
    

    >> Share

    
    
73. EL FRAKCHI N, El Kinany K, El Baldi M, Saoud Y, et al
    Dietary total antioxidant capacity of Moroccan Type 2 Diabetes Mellitus patients.
    PLoS One. 2024;19:e0301805.
    

    >> Share

    
    
74. CHAVEZ-TAPIA NC, Sanchez-Jimenez BA, Vidana-Perez D, Corrales-Rosas B, et al
    Predictors for liver fibrosis in non-alcoholic patients with psoriatic diseases: A multicenter cross sectional-study.
    PLoS One. 2024;19:e0290632.
    

    >> Share

    
    
75. SOLOUKI S, Gorgani-Firuzjaee S, Jafary H, Delfan M, et al
    Efficacy of high-intensity interval and continuous endurance trainings on cecal microbiota metabolites and inflammatory factors in diabetic rats induced by high-fat diet.
    PLoS One. 2024;19:e0301532.
    

    >> Share

    
    
76. ALANAZI M, Bajmal E, Aseeri A, Alsulami G, et al
    Empowering adult patients with diabetes for health educators' role within their family members: A cross-sectional study.
    PLoS One. 2024;19:e0299790.
    

    >> Share

    
    
77. SANJARI E, Raeisi Shahraki H, G Khachatryan L, Mohammadian-Hafshejani A, et al
    Investigating the association between diabetes and carpal tunnel syndrome: A systematic review and meta-analysis approach.
    PLoS One. 2024;19:e0299442.
    

    >> Share

    
    
78. PAN T, Bai L, Zhu D, Wei Y, et al
    The causal relationship between genetically predicted blood metabolites and idiopathic pulmonary fibrosis: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0300423.
    

    >> Share

    
    
79. TAKAHASHI N, Ichii O, Hiraishi M, Namba T, et al
    Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice.
    PLoS One. 2024;19:e0302041.
    

    >> Share

    
    
80. SALEH NKM, Mohamed AEA, Moussa MH, Assal Y, et al
    Garlic oil improves small intestinal motility in experimentally induced type II diabetes mellitus in female Wistar rats.
    PLoS One. 2024;19:e0301621.
    

    >> Share

    
    
81. OH JI, Lee KJ, Hipp A
    Food deserts exposure, density of fast-food restaurants, and park access: Exploring the association of food and recreation environments with obesity and diabetes using global and local regression models.
    PLoS One. 2024;19:e0301121.
    

    >> Share

    
    
82. LIU X, Zhu H, Peng Y, Liu Y, et al
    Twenty-Four week Taichi training improves pulmonary diffusion capacity and glycemic control in patients with Type 2 diabetes mellitus.
    PLoS One. 2024;19:e0299495.
    

    >> Share

    
    
83. KUZNETSOVA KG, Vasicek J, Skiadopoulou D, Molnes J, et al
    Bioinformatics pipeline for the systematic mining genomic and proteomic variation linked to rare diseases: The example of monogenic diabetes.
    PLoS One. 2024;19:e0300350.
    

    >> Share

    
    
84. OJO OA, Ogunlakin AD, Akintayo CO, Olukiran OS, et al
    Spilanthes filicaulis (Schumach. & Thonn.) C.D. Adams leaves protects against streptozotocin-induced diabetic nephropathy.
    PLoS One. 2024;19:e0301992.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

85. WOO JR, Bae SH, Wales TE, Engen JR, et al
    The serine phosphorylations in the IRS-1 PIR domain abrogate IRS-1 and IR interaction.
    Proc Natl Acad Sci U S A. 2024;121:e2401716121.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share